The General Incorporated Association Next Generation Medicine Japan (Location: Nakanoshima, Kita-ku, Osaka City, Osaka Prefecture; hereinafter referred to as "the Association") was established on May 1, 2026, and has commenced full-scale activities to create a Longevity social implementation ecosystem. The Association aims to disseminate Japan's strengths in healthy longevity to the world and to build a new ecosystem that connects medicine, life sciences, technology, and industry, centered on Longevity (healthy longevity and extension of healthspan). ■ Why Longevity Now? With the rapid evolution of AI, biotechnology, and gene editing technologies, controlling aging and regenerative medicine are becoming realistic options. Coupled with accelerating aging and increased health awareness in the post-COVID era, the question of "how to continue living a healthy and fulfilling life" rather than "how long to live" has become a global challenge. The concept of the "Longevity Economy" is already spreading in Europe and the United States, with a full-scale movement to review society as a whole, not just medicine, but also education, employment, finance, and community development. The World Economic Forum (WEF) has also positioned "Building Sustainable Societies in the Age of Longevity" as a key issue and proposed six principles, including promoting healthy aging and creating environments for multi-generational employment and learning. In terms of business, investment in "Longevity Tech" is rapidly increasing, with investment in related startups exceeding $10 billion (approximately 1.5 trillion yen) in just three years from 2022 to 2024. Amidst this global trend, Japan has the potential to become the "largest demonstration field" for Longevity. To leverage this potential, the Association has begun its activities in conjunction with Next Generation Medicine in the United States. ■ Japan's Role and Current Challenges: Possessing the World's Largest Longevity Data but Lagging in C